SCHEMBL19923740

SCHEMBL19923740

CN1C(=O)N(C)C(C)(c2ccccc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.46
HTR6 P50406 3/20 0.46
PKM P14618 1/20 0.44
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
PAX8 Q06710 1/20 0.42
MCL1 Q07820 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BACE1 P56817 5/20 0.42
BACE2 Q9Y5Z0 4/20 0.42
APP P05067 2/20 0.42
REN P00797 1/20 0.42
HTR7 P34969 2/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
PLA2G7 Q13093 1/20 0.38
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
CTSD P07339 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923559 0.79 HTR1A (0.42) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923728 0.79 PKM (0.40) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL17830174 0.78 HTR1A (0.46) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923754 0.76 HTR1A (0.41) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923573 0.76 HTR1A (0.43) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923472 0.76 ALDH1A1 (0.41) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923700 0.75 HTR1A (0.40) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923549 0.75 TSHR (0.38) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL19923407 0.74 TSHR (0.37) HTR1AHTR6PKMALDH1A1LMNA
SCHEMBL9841223 0.74 BACE1 (0.46) HTR1AHTR6PKMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN HTR1A 456/4885HTR6 77/4885PKM 1356/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM HTR1A 341/4885HTR6 77/4885PKM 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.